Serina Therapeutics (SER) Retained Earnings (2017 - 2025)
Historic Retained Earnings for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to -$60.2 million.
- Serina Therapeutics' Retained Earnings fell 17629.85% to -$60.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$60.2 million, marking a year-over-year decrease of 17629.85%. This contributed to the annual value of -$44.3 million for FY2024, which is 3358.05% down from last year.
- As of Q3 2025, Serina Therapeutics' Retained Earnings stood at -$60.2 million, which was down 17629.85% from -$55.6 million recorded in Q2 2025.
- Serina Therapeutics' Retained Earnings' 5-year high stood at -$5.4 million during Q1 2024, with a 5-year trough of -$127.6 million in Q3 2023.
- Its 5-year average for Retained Earnings is -$80.1 million, with a median of -$101.6 million in 2021.
- Per our database at Business Quant, Serina Therapeutics' Retained Earnings surged by 9545.19% in 2024 and then crashed by 80397.42% in 2025.
- Quarter analysis of 5 years shows Serina Therapeutics' Retained Earnings stood at -$105.7 million in 2021, then dropped by 9.89% to -$116.2 million in 2022, then surged by 71.45% to -$33.2 million in 2023, then plummeted by 33.58% to -$44.3 million in 2024, then crashed by 35.76% to -$60.2 million in 2025.
- Its Retained Earnings stands at -$60.2 million for Q3 2025, versus -$55.6 million for Q2 2025 and -$49.1 million for Q1 2025.